The Chemours Newsroom

Chemours Is Maintained at Buy by UBS

Dow JonesMay 7 10:54 ET

Chemours Analyst Ratings

BenzingaMay 7 10:44 ET

Alembic Global Maintains The Chemours(CC.US) With Buy Rating, Cuts Target Price to $18

Moomoo NewsMay 7 02:45 ET

Research Alert: Chemours Reports Mixed Q1 Results, Lowers Top End Of Fy 25 Guidance Slightly

MT NewswiresMay 6 18:15 ET

Mizuho Securities Maintains The Chemours(CC.US) With Buy Rating, Cuts Target Price to $15

Moomoo NewsApr 16 02:34 ET

Truist Financial Maintains The Chemours(CC.US) With Buy Rating, Cuts Target Price to $22

Moomoo NewsApr 15 02:41 ET

Chemours Is Maintained at Buy by Truist Securities

Dow JonesApr 14 09:07 ET

Chemours Analyst Ratings

BenzingaApr 14 08:57 ET

RBC Capital Maintains The Chemours(CC.US) With Buy Rating, Cuts Target Price to $17

Moomoo NewsApr 10 03:33 ET

UBS Maintains The Chemours(CC.US) With Buy Rating, Cuts Target Price to $18

Moomoo NewsApr 8 02:33 ET

BMO Capital Maintains The Chemours(CC.US) With Buy Rating, Cuts Target Price to $21

Moomoo NewsApr 8 02:33 ET

Chemours Is Maintained at Equal-Weight by Barclays

Dow JonesApr 1 10:21 ET

Barclays Maintains The Chemours(CC.US) With Hold Rating, Cuts Target Price to $16

Moomoo NewsApr 1 04:32 ET

BMO Capital Maintains The Chemours(CC.US) With Buy Rating, Maintains Target Price $27

Moomoo NewsApr 1 02:33 ET

Chemours Analyst Ratings

BenzingaMar 27 06:51 ET

Mizuho Securities Upgrades The Chemours(CC.US) to Buy Rating, Announces Target Price $19

Moomoo NewsMar 27 02:31 ET

RBC Capital Maintains The Chemours(CC.US) With Buy Rating, Maintains Target Price $25

Moomoo NewsMar 25 02:31 ET

Mizuho Securities Maintains The Chemours(CC.US) With Hold Rating

Moomoo NewsMar 13 04:32 ET

Barclays Maintains The Chemours(CC.US) With Hold Rating, Maintains Target Price $19

Moomoo NewsMar 13 04:32 ET

Chemours Price Target Cut to $19.00/Share From $23.00 by Barclays

Dow JonesFeb 24 09:17 ET